Rise and Scantox cease conducting animal testing in Stockholm

Access to in vivo toxicology services is significantly decreasing in the Stockholm area as Rise shuts down animal testing and Scantox reorganizes. ”The costs ar...

FHM ska leda expertlabb för ebola och okända virussjukdomar

Folkhälsomyndigheten har fått ansvar för att driva det europeiska referenslaboratoriet för smittsamma sjukdomar som ebola, marburg och rabies. Uppdraget omfatta...

ZEISS Hosts an exceptional Global Conference on Innovation and Production in Berlin

More than 50 distinguished speakers from leading manufacturing companies.

ProPharma

Aurevia

Tryckreglering med global expertis – OEM Automatic erbjuder lösningar från Tescom

OEM Automatic tillhandahåller tryckregulatorer och ventiler från Tescom – en erkänd aktör med över ett sekel av erfarenhet inom precisionsstyrning av gaser och ...

AI detects tumor disease – via voice recording

A short voice recording along with facial images – both analyzed with an AI algorithm – can make it possible to detect the rare tumour disease acromegaly and in...

Vinnova is going to establish a new innovation cluster

Vinnova, the Swedish Agency for Innovation Systems, has been commissioned by the government to establish a national innovation cluster for advanced medicines.

Oncozenges tablett mot munsmärta utlicensieras för Gulf-regionen

Oncozenge har ingått ett licensavtal med Dubaibaserade Avernus Pharma om kommersialisering i Gulf-regionen av Bupizenge, en sugtablett under utveckling för beha...

Wusson Accelerator AB

Japanese pharma to buy US drugmaker for $2.4 bln

Japanese Ono Pharmaceutical buys the American cancer drug developer Deciphera Pharmaceuticals in one of the largest acquisitions in the industry so far this year.

Positiva data för vaccin i pulverform – ”Fungerar lika bra”

En ny studie indikerar att ett nytt influensavaccin, som utvecklas av Abera Bioscience i samarbete med Orexo, fungerar både som sprej och pulver.

High-tech companies are increasingly focusing on health

Tech companies have been taking an interest in healthcare for many years, and this interest seems to be increasing. “It’s not a sudden shift in trend, it’s more...

Bayer förlorar flerårig strid mot generikabolag – patent ogiltigförklaras i Sverige

En långdragen patenttvist mellan Bayer och Mylan är avgjord. Patent- och marknadsöverdomstolen fastställer beslutet som ogiltigförklarar Bayers patent för ett c...

The Swedish Foundation for Strategic Research

ZEISS Metrology Expert Tips

New video series provides valuable expert knowledge.

Exakt tryckreglering med Tescom – när precision är avgörande

OEM Automatic erbjuder ett brett sortiment av tryckregulatorer från Tescom – anpassade för att möta höga krav inom allt från gasleveranssystem till avancerad in...

From powder to implant

Quality assurance for additively manufactured implants.

Enhance your expertise with your measuring software

Discover the training options in our ZEISS Metrology Portal.

The first drugs to slow down Alzheimer’s – but what does it mean for patients?

New treatments for early Alzheimer’s are bringing hope to thousands of patients and their families. The question is, who will get the treatment, how will the ri...

The fast route to a safe insulin pen

Diabetes is on the rise worldwide with around ten million people developing the disease every year. Demand for insulin pens allowing patients to self-medicate i...

Her company is developing a new tablet form obesity drug

Obesity and diabetes are the primary targets of a new tablet treatment under development by Malmö-based Pila Pharma. The company’s ambition is to take on the bi...

Column: ”We need to exploit the benefits of the regulations“

You don’t need to search long on the Internet to find lists of the most innovative countries with Sweden ranking at the top. Sweden generally offers good condit...

MSD discontinues two Keytruda trials

MSD has stopped two late-stage trials that tested its blockbuster immunotherapy Keytruda as a treatment for skin and lung cancer.